Cardiomyopathy Clinical Trials in Beijing, Beijing Municipality
16 recruitingBeijing, Beijing Municipality, China
Showing 1–16 of 16 trials
Recruiting
Phase 3
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Novo Nordisk A/S1,280 enrolled289 locationsNCT07207811
Recruiting
Phase 1
A Bioequivalence Study of Two Formulations of HRS-1893 Tablets in Healthy Participants
Cardiomyopathy
Shandong Suncadia Medicine Co., Ltd.36 enrolled1 locationNCT07479641
Recruiting
A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China
Hypertrophic Cardiomyopathy
Bristol-Myers Squibb500 enrolled15 locationsNCT07361289
Recruiting
Phase 1Phase 2
Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases
TumorCardiovascular DiseasesPulmonary Fibrosis+3 more
Peking Union Medical College Hospital30 enrolled1 locationNCT07464132
Recruiting
Phase 2
PET Myocardial Fatty-acid Metabolic Imaging With XTR003 Injection and 18F-FDG to Assess Myocardial Viability in Ischemic Cardiomyopathy
Heart FailureIschemic Cardiomyopathy
Sinotau Pharmaceutical Group40 enrolled3 locationsNCT07443696
Recruiting
The Application of T1 Mapping in Real-World
Hypertrophic Cardiomyopathy (HCM)MyocarditisMyocardial Infarction (MI)+2 more
Chinese Academy of Medical Sciences, Fuwai Hospital2,000 enrolled1 locationNCT07354646
Recruiting
Phase 1
A Phase I Trial on the Relative Bioavailability and Food Effect of HRS-1893 Tablets in Healthy Subjects
Cardiomyopathy
Shandong Suncadia Medicine Co., Ltd.38 enrolled1 locationNCT07272330
Recruiting
Not Applicable
REFINE-HCM: Intramyocardial Septal Radiofrequency Ablation for Obstructive Hypertrophic Cardiomyopathy
Hypertrophic Cardiomyopathy, Obstructive
SuZhou Sinus Medical Technologies Co.,Ltd124 enrolled2 locationsNCT07006493
Recruiting
Phase 2
A Clinical Study to Evaluate the Long-term Safety of HRS-1893 in Hypertrophic Cardiomyopathy
Hypertrophic Cardiomyopathy
Shandong Suncadia Medicine Co., Ltd.300 enrolled1 locationNCT07021963
Recruiting
Phase 3
A Phase III Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy
Obstructive Hypertrophic Cardiomyopathy
Shandong Suncadia Medicine Co., Ltd.216 enrolled1 locationNCT07021976
Recruiting
Not Applicable
LBBP as Initial Therapy in Patients With Non-ischemic Heart Failure and LBBB
Heart FailureNon-ischemic CardiomyopathyLeft Bundle-Branch Block
The First Affiliated Hospital with Nanjing Medical University50 enrolled6 locationsNCT05572957
Recruiting
Phase 2
A Phase II Clinical Study of HRS-1893 in Non-obstructive Hypertrophic Cardiomyopathy
Non-obstructive Hypertrophic Cardiomyopathy
Shandong Suncadia Medicine Co., Ltd.84 enrolled1 locationNCT06816251
Recruiting
Phase 1Phase 2
A Phase I/IIa，Open-label, Single Ascending Dose and Dose-expansion Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of YOLT-201 in Patients With Transthyretin Amyloidosis Polyneuropathy (ATTR-PN) or Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
Transthyretin Amyloidosis PolyneuropathyTransthyrexin Amyloidosis Cardiomyopathy
YolTech Therapeutics Co., Ltd31 enrolled3 locationsNCT06539208
Recruiting
Phase 4
Use of SGLT2i in noHCM With HFpEF
Hypertrophic CardiomyopathyHeart Failure With Preserved Ejection Fraction
China National Center for Cardiovascular Diseases94 enrolled1 locationNCT06401343
Recruiting
Cardiac Magnetic Resonance for Risk Stratification in Dilated Cardiomyopathy
Dilated CardiomyopathySingle-center Study
Chinese Academy of Medical Sciences, Fuwai Hospital2,500 enrolled1 locationNCT04990297
Recruiting
The Chinese Hypertrophic Cardiomyopathy Study(CHCS)
Cardiomyopathy, Hypertrophic
China National Center for Cardiovascular Diseases3,000 enrolled1 locationNCT02696135